However, its GLP-1-based mechanism of action could theoretically increase the risk of certain cancers [15]
[DOI] [PMC free article] [PubMed] [Google Scholar] 80.Wang W, Volkow ND, Berger NA, Davis PB, Kaelber DC, Xu R
Adiposity & Body Composition Animal and clinical trial datasets describe substantial reductions in fat mass over 24- and 48-week protocols, with investigators attributing the magnitude to combined incretin and glucagon-receptor effects on intake and expenditure
However, it does not produce the rapid or substantial weight loss typically seen with prescription GLP-1 medications
All mice showed a physiological extracranial [ 18 F]-FDG distribution with normal uptake in the Harderian glands, brown adipose tissue, myocardium, kidneys, gastrointestinal tract and urinary bladder
Some researchers have also used plasma Insulin levels with the immunometric assay technology or GLP-1 levels to diagnose PH [26]